New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.

PubWeight™: 1.95‹?› | Rank: Top 2%

🔗 View Article (PMID 8642184)

Published in J Hum Hypertens on January 01, 1996

Authors

F Gueyffier1, A Froment, M Gouton

Author Affiliations

1: Unité 60, Hôpital Cardiologique Louis Pradel, Lyon, France.

Articles citing this

Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? CMAJ (1999) 3.26

Persistence with treatment for hypertension in actual practice. CMAJ (1999) 2.74

Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey. BMJ (2000) 2.55

The Secondary Prevention of Small Subcortical Strokes (SPS3) study. Int J Stroke (2011) 2.35

Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial. J Stroke Cerebrovasc Dis (2012) 1.47

What are the elements of good treatment for hypertension? BMJ (2001) 1.28

Evaluating Chicago's success in reaching the Healthy People 2000 goal of reducing health disparities. Public Health Rep (2002) 1.14

Hypertension Improvement Project (HIP): study protocol and implementation challenges. Trials (2009) 1.13

Predictors of decline in medication adherence: results from the cohort study of medication adherence among older adults. Hypertension (2011) 1.11

A comparison of live counseling with a web-based lifestyle and medication intervention to reduce coronary heart disease risk: a randomized clinical trial. JAMA Intern Med (2014) 1.00

Olmesartan/amlodipine: a review of its use in the management of hypertension. Vasc Health Risk Manag (2011) 0.89

The global risk approach should be better applied in French hypertensive patients: a comparison between simulation and observation studies. PLoS One (2011) 0.87

Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trial. Am J Hypertens (2013) 0.85

Modern management of hypertension and heart failure: evidence and practice. Heart (2000) 0.80

Designing and implementing a comparative effectiveness study of two strategies for delivering high quality CHD prevention: methods and participant characteristics for the Heart to Health study. Contemp Clin Trials (2013) 0.80

Hypertension and Health Behaviors in Females Across the Lifespan. Am J Med Sci (2015) 0.75

High Risk versus Proportional Benefit: Modelling Equitable Strategies in Cardiovascular Prevention. PLoS One (2015) 0.75

Are we using blood pressure-lowering drugs appropriately? Perhaps now is the time for a change. J Hum Hypertens (2013) 0.75

Primary prevention of CVD: treating hypertension. BMJ Clin Evid (2010) 0.75

Articles by these authors

Prevalence of overweight and obesity for urban adults in Cameroon. Ann Hum Biol (2003) 1.34

[Relationship of sodium intake and arterial hypertension. Contribution of geographical epidemiology (author's transl)]. Rev Epidemiol Sante Publique (1979) 1.24

Isolation and molecular characterization of a human T-cell lymphotropic virus type II (HTLV-II), subtype B, from a healthy Pygmy living in a remote area of Cameroon: an ancient origin for HTLV-II in Africa. Proc Natl Acad Sci U S A (1995) 1.05

Age at menarche and urbanization in Cameroon: current status and secular trends. Ann Hum Biol (1999) 1.01

[Anopheles species and the transmission of malaria in the forest/savannah transition zone in central Cameroon]. Bull Soc Pathol Exot (1997) 1.01

HTLV-II among pygmies from Cameroon. AIDS Res Hum Retroviruses (1993) 0.92

Massive overfeeding and energy balance in men: the Guru Walla model. Am J Clin Nutr (1992) 0.91

Selection of three strains of rats with spontaneously different levels of blood pressure. Biomedicine (1973) 0.84

The correlations between anthropobiological and climatic variables in sub-Saharan Africa: revised estimates. Hum Biol (1976) 0.83

Is cell-mediated immune response related to nutritional state, but unaffected by concomitant malarial infection? Ann Trop Med Parasitol (1982) 0.82

[Rubella epidemiology in rural Upper Volta]. Acta Trop (1982) 0.82

[Morphologic differentiation of modern humans: correspondence between skull form and geographic distribution of population]. C R Acad Sci III (1992) 0.81

Alcohol consumption and blood pressure in a French epidemiological study. Eur Heart J (1982) 0.81

Climate-associated anthropometric variation between populations of the Niger bend. Ann Hum Biol (1984) 0.79

Effects of interventions on community awareness and treatment of hypertension: results of a WHO study. Bull World Health Organ (1988) 0.78

Hepatitis C in remote populations of southern Cameroon. Ann Trop Med Parasitol (1994) 0.78

[Cardiac tamponade by right atrial laceration due to blunt chest trauma in a 3-year-old child]. Ann Fr Anesth Reanim (2010) 0.77

[Measles vaccination in the Sudan-Sahel region of Africa. Absence of the immunodepressive effect of malaria]. Pathol Biol (Paris) (1985) 0.76

[Efficacy of measles vaccination in young malnourished African children]. Bull Soc Pathol Exot Filiales (1984) 0.76

[Infectious endocarditis induced by Actinobacillus actinomycetemcomitans. 8 new cases]. Arch Mal Coeur Vaiss (1994) 0.76

[Control of urinary schistosomiasis by 3 annual courses of metrifonate]. Ann Soc Belg Med Trop (1981) 0.76

[Adrenal vein catheterization in primary hyperaldosteronism: aid in surgical decision making?]. Arch Mal Coeur Vaiss (2001) 0.75

[Treatment of arterial hypertension with polythiazide and guanoxan]. Lyon Med (1969) 0.75

[Glycyrrhizin and apparently essential arterial hypertension (5 cases)]. Arch Mal Coeur Vaiss (1968) 0.75

[Does glycyrrhizin act by stimulation of the adrenal cortex? Biologic simulation of Conn's syndrome by glycyrrhizin poisoning]. Rev Lyon Med (1968) 0.75

[Radiology in renovascular hypertension from i.v. urography to digital subtraction angiography. A critical evaluation]. J Radiol (1986) 0.75

[Primary cardiac amyloidosis. A further anatomo-clinical case]. Lyon Med (1966) 0.75

[Sodium restriction, natriuretics and hypotensors. Study of their respective value in arterial hypertension]. Rev Lyon Med (1968) 0.75

[Spontaneous mortality and vascular lesions in 3 rat strains with different blood pressure levels]. C R Acad Sci Hebd Seances Acad Sci D (1975) 0.75

[The renin-angiotensin system and the sympathetic nervous system in essential hypertension]. Arch Mal Coeur Vaiss (1982) 0.75

[Study of an association of spironolactone and salidiuretic in the treatment of cardiac insufficiency]. Sem Ther (1968) 0.75

[Acute hemorrhagic pancreatitis complicated by a voluminous, subsequently suppurative, hematoma of the abdominal wall]. Lyon Med (1965) 0.75

[Nutrition and anthropobiology]. Tiers Monde (1993) 0.75

[Study of habituation during long-term antihypertension therapy]. Rev Lyon Med (1969) 0.75

[Respective value of various functional renal exploration methods in hypertensive patients]. Rev Lyon Med (1969) 0.75

[Medical treatment of arterial hypertension]. Lyon Med (1971) 0.75

[Influence of the venous puncture technic and of delay of centrifugation on the measurement of blood potassium]. Lyon Med (1972) 0.75

[Contribution of digital venous angiography to the evaluation of arterial hypertension. Cost evaluation]. Arch Mal Coeur Vaiss (1985) 0.75

[Information from the medical service. I. What advantages are there in the informational administration of patients' hospital records?]. Nouv Presse Med (1980) 0.75

[Various characteristics related to the presence of a complication due to atherosclerosis in hospitalized hypertensive patients]. Rev Lyon Med (1968) 0.75

[Abnormal hemoglobins and thalassemias in Upper-Volta (author's transl)]. Bull Soc Pathol Exot Filiales (1982) 0.75

[Hypertension refractory to treatment. Case-control study]. Arch Mal Coeur Vaiss (1984) 0.75

[The Lyons Hypertension Control Program (1972-1978). Community analysis]. Arch Mal Coeur Vaiss (1986) 0.75

[Necessary prevention of the complications of hypertension. I]. Nouv Presse Med (1975) 0.75

[Health indicators of a population in an agro-industrial complex of southern Cameroon]. Sante (1995) 0.75

[Comparison of hospitalized hypertensive patients and those consulting in a specialized unit. Initial clinical state and patient compliance]. Arch Mal Coeur Vaiss (1979) 0.75

[Arterial pressure in school-age children. Relation to several variables]. Bull Inst Natl Sante Rech Med (1971) 0.75

Hepatitis B infection and the prevention of primary hepatocellular carcinoma: studies in Senegal. Prog Med Virol (1981) 0.75

[Value and role of echo-Doppler in the screening of renovascular hypertension. A prospective study of 144 arteries with reference to angiography]. Arch Mal Coeur Vaiss (1993) 0.75

[Sports and blood pressure: association in a population of wage-earners]. Arch Mal Coeur Vaiss (1986) 0.75

[Cardiovascular effects of the consumption of weak doses of glycyrrhizin. Preliminary results obtained during an epidemiologic survey]. Rev Lyon Med (1968) 0.75

Hypertension effective control. Nurs J Singapore (1978) 0.75

[Evaluation of the effects of malnutrition and malaria on skin reactions in delayed hypersensitivity to tuberculin, varidase and phytohemagglutinin]. Pathol Biol (Paris) (1983) 0.75

[The hazard of local anesthesia with procaine and lignocaine in Adams-Stokes disease]. Coeur Med Interne (1967) 0.75

[Sodium and arterial hypertension]. Bord Med (1971) 0.75

Protein patterns of Upper Volta children as a function of age and nutritional status. Ann Soc Belg Med Trop (1983) 0.75

[A severe disease: common essential arterial hypertension. The necessity of confirming it. The only possible management, its early and continuous treatment]. Therapeutique (1969) 0.75

[Reducing the burden of hypertension on the community. From control to prevention (author's transl)]. Rev Epidemiol Sante Publique (1978) 0.75

[Hypertension due to glycyrrhiza poisoning. Forms and frequency]. Lyon Med (1968) 0.75

[Arterial hypertension after the age of 60]. Bord Med (1971) 0.75

[Adjunction of spironolactone to anti-hypertensive treatment with thiazides. Double blind study]. Presse Med (1971) 0.75

[Chronic nephropathy, hypertension and analgesic abuse]. Lyon Med (1968) 0.75

[Respective roles of hemodynamic or humoral factors and of hypotensive or salidiuretic drugs in the development of essential hypertension]. Pathol Biol (1965) 0.75

[Blood pressure distributions in children (study of a group of 520 school-age boys)]. Bull Inst Natl Sante Rech Med (1971) 0.75

[End-stage heart failure: quantity or quality of life?]. Arch Mal Coeur Vaiss (2005) 0.75

[Angiographic and microangiographic study of the kidney druing the development of hypertension due to sclerous perinephritis in dogs]. Rev Lyon Med (1968) 0.75

[Determination of renin activity and aldosteronuria in 24 hypertensives]. Rev Lyon Med (1968) 0.75

[Case control and inter-case study of 48 surgically treated renovascular hypertensive patients]. Arch Mal Coeur Vaiss (1982) 0.75

[Primary prevention of hypertension in the general population. The Lyon Action for the Prevention of Hypertension and Atherosclerosis]. Arch Mal Coeur Vaiss (1991) 0.75

[Clinical pharmacology of natriuretics in arterial hypertension]. Rev Lyon Med (1969) 0.75

[Search for stenosis of the renal artery in arterial hypertension. Furosemide "wash-out" method]. Nouv Presse Med (1974) 0.75

[Should borderline hypertension be treated?]. Rev Prat (1984) 0.75

Mitral valve prolapse and infective endocarditis. Eur Heart J (1984) 0.75

Computer-assisted patient-care management. Med Inform (Lond) (1979) 0.75

[Estimation of the frequency of reno-vascular hypertension among unselected hypertensives (author's transl)]. Rev Epidemiol Sante Publique (1977) 0.75

[Development of tension numbers associated with arterial hypertension. Preliminary data based on a retrospective study]. Lyon Med (1968) 0.75

[Hyperkalemia during lymphoid leukemia as a possible cause of sudden death]. Lyon Med (1965) 0.75

[Against routine coronary angiography after myocardial infarction]. Ann Cardiol Angeiol (Paris) (1990) 0.75

[Case of cardiac transplantation for fully developed myocardiopathy]. Arch Mal Coeur Vaiss (1969) 0.75

[Sodium in experimental hypertension]. Pathol Biol (1965) 0.75

[Prediction and prognosis of diabetes incidence in treated hypertensive patients]. Arch Mal Coeur Vaiss (1985) 0.75

[Medical treatment of arterial hypertension in adults]. Rev Prat (1973) 0.75

[Epidemiology: key to understanding and combatting hypertension]. Rev Prat (1979) 0.75

General considerations on endemic treponematosis in the rural Sahel region of Upper Volta. Acta Trop (1983) 0.75

[Study of relations between weight changes and arterial pressure in 2 groups of normal patients]. Rev Lyon Med (1969) 0.75

[The prognosis of treated arterial hypertension]. Rev Prat (1973) 0.75

[Terebrating rectal ulcerations during chronic amebiasis]. Lyon Med (1965) 0.75

Primary aldosteronism and adrenal incidentaloma. Rom J Intern Med (2000) 0.75

[Treatment of hypertension in adults]. Rev Infirm (1974) 0.75

[Necessary prevention of the complications of hypertension (II)]. Nouv Presse Med (1975) 0.75